EXTH-42. COMBINATION OF MAPK PATHWAY INHIBITORS AND IMMUNE CHECKPOINT BLOCKADE IN BRAF-MUTANT HIGH-GRADE GLIOMA

Authors: Jong-Whi Park, Stefan Grossauer, Wei Wang, Mathieu Daynac, Sharon Pitteri, Michelle Monje, Gerald Grant, Claudia Petritsch

Published: 2021-11-18

DOI: 10.1093/neuonc/noab196.681

Source: Full article